Search
for

    Glossary Pregabalin

    medication used to treat nerve pain and seizures

    Pregabalin, also known by the brand name Lyrica, is a medication primarily used to treat nerve pain, epilepsy, and generalized anxiety disorder. It works by binding to certain calcium channels in the nervous system, which helps to reduce the release of neurotransmitters involved in pain and seizure activity.

    Sort by

    Research 30 of 103

    1. Cosmetic side effects of antiepileptic drugs in adults with epilepsy Epilepsy & behavior · 2014 · 46 citations
    2. Refractory Trichodynia Treated Using Onabotulinumtoxin-A Pain Medicine · 2020 · 8 citations
    3. [Translated article] Sensitive Scalp: Diagnosis and Practical Management 2022 · 1 citations
    4. Why Do Promising Therapies Stall in Development and How Can We Move Them Forward? International Journal of Toxicology · 2017 · 1 citations
    5. 201 Pain digital biomarker detecting by epidermal biopotential flexible sensor and AI-based system Journal of Investigative Dermatology · 2023
    6. Cuero cabelludo sensible: diagnóstico y manejo práctico 2022 · 2 citations
    7. Farmácia Serpa Pinto, Porto e Serviços Farmacêuticos do Instituto Português Oncologia do Porto Francisco Gentil, EPE, Porto Open Repository of the University of Porto (University of Porto) · 2024
    8. Reporting on Adverse Clinical Events Clin-Alert · 2010
    9. Green Chemistry in the Pharmaceutical Industry 2010 · 300 citations
    10. Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes Frontiers in Neurology · 2022 · 35 citations
    11. Reporting on Adverse Clinical Events Clin-alert · 2008
    12. Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors Sexual Medicine Reviews · 2017 · 176 citations
    13. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    14. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects Case Reports · 2015 · 39 citations
    15. Psychocutaneous disease Journal of The American Academy of Dermatology · 2017 · 38 citations
    16. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document Journal of Cutaneous Medicine and Surgery · 2017 · 36 citations
    17. Nobiletin-loaded composite penetration enhancer vesicles restore the normal miRNA expression and the chief defence antioxidant levels in skin cancer Scientific Reports · 2021 · 34 citations
    18. Parkinson's disease and skin 2021 · 28 citations
    19. Hidradenitis Suppurativa Mayo Clinic Proceedings · 2015 · 27 citations
    20. Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies American Journal of Clinical Dermatology · 2024 · 10 citations
    21. Symptom management in inflammatory bowel disease Expert Review of Gastroenterology & Hepatology · 2015 · 8 citations
    22. Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review Dermatology and Therapy · 2021 · 7 citations
    23. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    24. Cutaneous Reactions to Drugs Elsevier eBooks · 2017 · 3 citations
    25. Management of Toxicities of Targeted Therapies Elsevier eBooks · 2018 · 2 citations
    26. An unusual side effect of azathioprine Clinical and Experimental Dermatology · 2015 · 2 citations
    27. Structure and Function of the Skin Elsevier eBooks · 2012 · 1 citations
    28. Effectiveness of Botulinum Toxin Type A for Trichodynia Associated with Hair Loss Disorders: A Retrospective Study Dermatology and Therapy · 2026
    29. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    30. Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need! American Journal of Clinical Dermatology · 2026